IDiyas

For the Inventor, By the Inventor

FI

Hormos Medical Corporation


USPTO Granted Patents = 22



Forward Citations = 33

Loading Chart...
Loading Chart...

41 inventors (with patents filed for the assignee):

goldMedal Risto Santti (6 out of 12 patents)

silverMedal Tomi Streng (6 out of 9 patents)

bronzeMedal Arja Marketta Kalapudas (6 out of 14 patents)

4.  Markku Anttila (4 out of 5 patents)

5.  Maire Eloranta (3 out of 9 patents)

6.  Kaija Halonen (3 out of 6 patents)

7.  Veli-Matti Lehtola (3 out of 4 patents)

8.  Marja Sodervall (3 out of 3 patents)

9.  Mikko Unkila (2 out of 8 patents)

10.  Helena Korte (2 out of 3 patents)

11.  Mervi Hiilovaara-Teijo (2 out of 2 patents)

12.  Patrik Eklund (2 out of 2 patents)

13.  Marja Södervall (2 out of 2 patents)

14.  Lauri V Kangas (2 out of 35 patents)

15.  Jenni Bernoulli (1 out of 2 patents)


22 patents:

1. 10780063 - Method for the treatment or prevention of lower urinary tract symptoms (2020-09-22),
2. 9993442 - Method for the treatment or prevention of lower urinary tract symptoms (2018-06-12),
3. 9855224 - Method for enhancing the bioavailability of ospemifene (2018-01-02),
4. 9566252 - Method for the alleviation of dyspareunia in women (2017-02-14),
5. 9114106 - Method for the treatment or prevention of lower urinary tract symptoms (2015-08-25),
6. 8962693 - Method for the treatment or prevention of lower urinary tract symptoms (2015-02-24),
7. 8772353 - Method for enhancing the bioavalability of ospemifene (2014-07-08),
8. 8758821 - Oral formulations of ospemifene (2014-06-24),
9. 8642079 - Solid formulations of ospemifene (2014-02-04),
10. 8470890 - Method for enhancing the bioavailability of ospemifene (2013-06-25),
11. 8293947 - Method for the preparation of therapeutically valuable triphenylbutene derivatives (2012-10-23),
12. 8236861 - Method for enhancing the bioavailablity of ospemifene (2012-08-07),
13. 7825107 - Method of treating men suffering from chronic nonbacterial prostatitis with SERM compounds or aromatase inhibitors (2010-11-02),
14. 7812197 - Method for the preparation of therapeutically valuable triphenylbutene derivatives (2010-10-12),
15. 7582677 - Lignan formulations (2009-09-01),
Hormos Medical Corporation is a leading medical device company specialized in developing innovative solutions for cancer treatment. With a focus on precision medicine and personalized therapies, they aim to improve patient outcomes and quality of life. Their state-of-the-art medical devices and technologies are designed to enhance the efficiency and effectiveness of cancer treatments. Hormos Medical Corporation is committed to advancing cancer care and making a positive impact in the lives of patients and healthcare professionals.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

22 Patents

#6 in

#153 in Finland

#27,846 in the World

...
FI

Hormos Medical Corporation

Forward Citations = 33

41 inventors:

goldMedal Risto Santti (6 out of 12 patents)

silverMedal Tomi Streng (6 out of 9 patents)

bronzeMedal Arja Marketta Kalapudas (6 out of 14 patents)

4.  Markku Anttila (4 out of 5 patents)

5.  Maire Eloranta (3 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…